Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

483 results found

Use advanced search filters to refine your search

Search

2 filters applied

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
"互联网+医疗"领域的主要业务类型及其关注热点（续）Q&A
如前期所述，互联网健康咨询的服务范围主要包括线上健康评估、健康指导、健康宣教、就诊指导、心理疏导等非诊疗行为的"信息服务业务"；&#
ChinaFood, Drugs, Healthcare, Life Sciences
AnJie Broad Law Firm
Article
The Draft Of New Judicial Interpretation On PRC Antitrust Law - Part II: Changes To Substantive Matters
On November 18, 2022, the Supreme People's Court of the People's Republic of China published an announcement soliciting public comments on the draft of Provisions of the Supreme People's Court of the People's Republic of China ...
ChinaAntitrust/Competition Law
AnJie Broad Law Firm

Han Kun • Opinion | Implementation And Regulation Of DCT (Decentralized Clinical Trials) In China

The concept of "patient-centered" has become the core guiding ideology of current drug development. "Patient-centered" drug development refers to the process...

ChinaFood, Drugs, Healthcare, Life Sciences

Han Kun Law Offices

如何为"已知物质"的新医药用途争取专利保护？ ——中国审查实务深度解析与策略指南

药物的研发具有周期长、投入高、风险大、技术难度高的显著特点。

ChinaIntellectual Property

CCPIT Patent and Trademark Law Office

AFD China Newsletter - May 2022

It is clearly stipulates in the Provisions that the first-instance trial of civil and administrative cases involving the ownership of and

ChinaIntellectual Property

浅谈"瑞士型制药用途权利要求"中的给药步骤类特征

医药行业在当今科技发展中具有重要的地位，医药产业相关发明的专利申请量也在逐年递增。然而各国当前对医药相关发明、特别是涉及给药

ChinaIntellectual Property

原研药企业的潜在反垄断风险介绍

近期，医疗领域掀起了力度强劲的反腐风暴...

ChinaIntellectual Property

AnJie Broad Law Firm

China On The Move: Lessons From China's 2023 National Negotiation Of Drug Prices

In December 2023, China's National Healthcare Security Administration (NHSA) published the 2023 National Reimbursement Drug List (2023 NRDL), implementing a comparable level of pricing discounts...

ChinaFood, Drugs, Healthcare, Life Sciences

Greenberg Traurig

NMPA's Releases Draft Measures For Data Protection (Data Exclusivity)

In March 2025, China's National Medical Products Administration (NMPA) released yet another set of draft implementation measures on data protection.

ChinaFood, Drugs, Healthcare, Life Sciences

生命科学行业License-in/out合同争议要点分析（三）：不竞争条款

"不竞争条款（Non-Compete Clause）"是License-in/out交易中保障技术价值、

ChinaFood, Drugs, Healthcare, Life Sciences

Han Kun Law Offices

Highlights On The New Drug Recall Regulation Of 2022

On October 26, 2022, the National Medical Products Administration ("NMPA") issued the newly revised Measures for the Administration of Drug Recalls ("the 2022 Measures") that has just been formally adopted.

ChinaFood, Drugs, Healthcare, Life Sciences

Han Kun Law Offices

The Demand And Challenges Of Patent Protection For Combination Drug Therapy

Abstract: Combination drug therapy offers significant advantages in treating various diseases and has become important in drug development. With the rapid growth of China's innovative drug industry

ChinaFood, Drugs, Healthcare, Life Sciences

Lung Tin IP Attorneys

热议新版《药品管理法》：积极响应监管，把握行业机遇

此等问题的正解且待新药法实施细则和《药品注册管理办法》修订来澄清。

ChinaFood, Drugs, Healthcare, Life Sciences

DeHeng Law Offices

食品行业领域迎来强监管—— 新《食品安全法实施条例》解读

2019年10月11日，国务院发布《食品安全法实施条例》（国务院令第721号，...

ChinaFood, Drugs, Healthcare, Life Sciences

DeHeng Law Offices

Patenting Regenerative Medicine In China

Regenerative medicine, which aims at the process of replacing, engineering or regenerating human cells, tissues or organs, so as to restore or establish the normal function of a living organism ...

ChinaIntellectual Property

CCPIT Patent and Trademark Law Office

医药企业走出去的知识产权风险防范

近年来，随着国内医药企业创新投入的不断增加，企业创新实力不断增强，自主开发的创新药不断涌现，进入临床试验和获批上市的推进速度

ChinaIntellectual Property

CCPIT Patent and Trademark Law Office

2024 Data Analytics: China Life Sciences NewCo & Licensing Terms

License-in/out transactions have become a key strategic approach for innovative drug and medical device (including medical aesthetics) companies to expedite the research and development of the products and expand market presence.

ChinaFood, Drugs, Healthcare, Life Sciences

Han Kun Law Offices

合成生物学合规及投融资法律指南（三）——行业应用合规（医药篇）

合成生物学在医药、化妆品、农业、食品等各个行业都有广阔的应用场景，而每一具体行业项下的合规监管都各具特色。除本系列第二篇《合

ChinaFood, Drugs, Healthcare, Life Sciences

AnJie Broad Law Firm

干细胞与基因治疗领域扩大开放新政及CAR-T地方监管新规初探

近年来细胞和基因治疗（CGT）领域随着相关科学理论、技术手段和临床医疗实践的不断演进而蓬勃发展。

ChinaFood, Drugs, Healthcare, Life Sciences

AnJie Broad Law Firm

Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Of Our Country's Drug Review And Approval System (Part II)

In "Interpretation of China's Annual Drug Review Report (2015-2021) - Review of the Achievements of China's Drug Review and Approval System Reform (Part 1)"...

ChinaFood, Drugs, Healthcare, Life Sciences

Han Kun Law Offices

Showing 421–440 of 483 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics